Christina Young, PhD X-twitter Linkedin Google Dr. Young’s research aims to improve the detection and monitoring of early cognitive decline due to Alzheimer’s disease and related dementias. Her research relates novel assessments of cognition and functioning, on the one hand, to neuroimaging-based biomarker information, on the other.
Vicky Yao X-twitter Google There has been considerable progress in our understanding of genetics since the sequencing of the first human genome in the early 2000s. Sequencing and genomic measurement technologies continue to advance, yielding more and more high resolution snapshots of experimental and clinical states. The bottleneck now lies in cleaning, interpreting, and integrating
Tara Tracy, PhD X-twitter Synapses are specialized structures that are critical for the transmission of information between neurons in the brain. Fine-tuning of the electrochemical activity at synapses underlies cognitive processes. In Alzheimer’s disease, memory loss coincides with synapse deterioration. The Tracy lab is investigating the molecular events that lead to synapse dysfunction and cognitive
Miranda Good, PhD Linkedin X-twitter Miranda Good completed her PhD in Physiological Sciences at the University of Arizona. Her graduate research in Dr. Janis Burt’s Lab focused on the role of vascular connexins, Cx37 and Cx40, in regulation of proliferation and inflammation. As a post-doctoral fellow at the University of Virginia Robert M. Berne Cardiovascular
Maj-Linda B. Selenica, PhD Linkedin Facebook Currently Dr. Selenica lab’s research is focused on molecular pathways and therapeutic approaches toward neurodegenerative disease; especially Alzheimer’s Disease and related dementias. They have established an impressive tool kit of molecular biology tool, cellular models, antibodies etc to study the impact of post-translational modifications involved in tau and TDP-43
Maj-Linda B. Selenica Read More »
Chia-Ling Phuah, MD, MMSc Linkedin Chia-Ling Phuah, MD, MMSc, is a neurointensivist and physician-scientist in the Neurocritical Care Program, and an associate professor in the Department of Neurology at Barrow Neurological Institute. She is a faculty member of the Human Neurosciences Program and co-director of the Barrow Neuro Analytics Center. She is board certified in
Kevin Beier, PhD Linkedin Google Dr. Beier has a diverse educational and research background that drives me to take a non-traditional approach to neuroscience. His undergraduate education and early research was in biophysics and biochemistry, where he worked laboratory of M. Thomas Record in the Department of Chemistry at UW-Madison, investigating the thermodynamics of protein
